301 related articles for article (PubMed ID: 31171724)
1. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.
Ryan JJ; Sprunger ML; Holthaus K; Shorter J; Jackrel ME
J Biol Chem; 2019 Jul; 294(29):11286-11296. PubMed ID: 31171724
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
3. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
4. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
5. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Phosphorylation of a Prion-Like Domain Regulates Transformation by FUS-CHOP.
Chen M; Foster JP; Lock IC; Leisenring NH; Daniel AR; Floyd W; Xu E; Davis IJ; Kirsch DG
Cancer Res; 2021 Oct; 81(19):4939-4948. PubMed ID: 34385184
[TBL] [Abstract][Full Text] [Related]
7. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
8. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.
Theisen ER; Pishas KI; Saund RS; Lessnick SL
Oncotarget; 2016 Apr; 7(14):17616-30. PubMed ID: 26848860
[TBL] [Abstract][Full Text] [Related]
10. Specificity of fusion genes in adipocytic tumors.
Kubo T; Matsui Y; Naka N; Araki N; Myoui A; Endo K; Yasui N; Ohtani O; Suzuki K; Kimura T; Yoshikawa H; Ueda T
Anticancer Res; 2010 Feb; 30(2):661-4. PubMed ID: 20332486
[TBL] [Abstract][Full Text] [Related]
11. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
[TBL] [Abstract][Full Text] [Related]
12. Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma.
Johnson KM; Taslim C; Saund RS; Lessnick SL
PLoS One; 2017; 12(11):e0186275. PubMed ID: 29091716
[TBL] [Abstract][Full Text] [Related]
13. Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.
Jackrel ME; Shorter J
Dis Model Mech; 2014 Oct; 7(10):1175-84. PubMed ID: 25062688
[TBL] [Abstract][Full Text] [Related]
14. IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.
Cironi L; Riggi N; Provero P; Wolf N; Suvà ML; Suvà D; Kindler V; Stamenkovic I
PLoS One; 2008 Jul; 3(7):e2634. PubMed ID: 18648544
[TBL] [Abstract][Full Text] [Related]
15. Detection of EWS/FLI-1 fusion in non-Ewing soft tissue tumors.
Trancău IO; Huică R; Surcel M; Munteanu A; Ursaciuc C
J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):114-9. PubMed ID: 25870707
[TBL] [Abstract][Full Text] [Related]
16. Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.
Gangwal K; Lessnick SL
Cell Cycle; 2008 Oct; 7(20):3127-32. PubMed ID: 18927503
[TBL] [Abstract][Full Text] [Related]
17. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis of liposarcomas: identification of the chimeric genes FUS/CHOP and EWS/CHOP].
Kekeeva TV; Riazantseva AA; Anreeva IuIu; Zavalishina LE; Babenko OV; Zaletaev DV; Petrov AN; Frank GA
Arkh Patol; 2009; 71(5):32-5. PubMed ID: 19938700
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
[TBL] [Abstract][Full Text] [Related]
20. Prion-like Domains Program Ewing's Sarcoma.
Shorter J
Cell; 2017 Sep; 171(1):30-31. PubMed ID: 28938120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]